Betamethasone pharmacokinetics after two prodrug formulations in sheep: Implications for antenatal corticosteroid use

Drug Metabolism and Disposition

Volumn 33, Issue 8, 2005, Pages 1124-1130

  Samtani, Mahesh N ^a   Löhle, Matthias L ^b   Grant, Angela ^c   Nathanielsz, Peter W ^b   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; FEMALE; HALF LIFE TIME; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; SLOW DRUG RELEASE;

ADRENAL CORTEX HORMONES; ANIMALS; BETAMETHASONE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; DELAYED-ACTION PREPARATIONS; FEMALE; FETAL BLOOD; MASS SPECTROMETRY; PREGNANCY; PRENATAL CARE; PRODRUGS; SHEEP;

OVIS ARIES;

EID: 22944446132     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.004309     Document Type: Article

References (40)

1. Andrews MH and Matthews SG (2003) Antenatal glucocorticoids: Is there cause for concern? Fetal and Maternal Medicine Review 14:329-354.
2. Ballard PL (1986) Hormones and lung maturation. Monogr Endocrinol 28:173-196.
3. Ballard PL and Ballard RA (1995) Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 173:254-262.
4. Ballard PL, Granberg P, and Ballard RA (1975) Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Investig 56:1548-1554.
5. Benet LZ, Oie S, and Schwartz JB (1996) Design and optimization of dosage regimens: pharmacokinetic data, in Goodman and Gilman's The Pharmacological Basis of Therapeutics (Hardman JG and Limbird LE eds) pp 1707-1792, McGraw-Hill Companies, New York.
6. D'Argenio DZ and Schumitzky A (1997) ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Biomedical Simulations Resource, Los Angeles.
7. Ding J and Neue UD (1999) A new approach to the effective preparation of plasma samples for rapid drug quantitation using on-line solid phase extraction mass spectrometry. Rapid Commun Mass Spectrom 13:2151-2159.
8. Dudley DJ, Waters TP, and Nathanielsz PW (2003) Current status of single-course antenatal steroid therapy. Clin Obstet Gynecol 46:132-149.
9. Dunlop SA, Archer MA, Quinlivan JA, Beazley LD, and Newnham JP (1997) Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med 6:309-313.
10. Frerichs VA and Tornatore KM (2004) Determination of the glucocorticoids prednisone, prednisolone, dexamethasone and cortisol in human serum using liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 802:329-338.
11. Gamsu HR, Mullinger BM, Donnai P, and Dash CH (1989) Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. Br J Obstet Gynaecol 96:401-410.
12. Gonzales LW, Ballard PL, Ertsey R, and Williams MC (1986) Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 62:678-691.
13. Harvey SC (1975) Hormones, in Remington's Pharmaceutical Sciences (Hoover JE ed) pp 879-934, Mack Publishing Company, Easton, PA.
14. Hirano K, Ichihashi T, and Yamada H (1981) Studies on the absorption of practically waterinsoluble drugs following injection. II. Intramuscular absorption from aqueous suspensions in rats. Chem Pharm Bull (Tokyo) 29:817-827.
15. Jobe AH and Soll RF (2004) Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol 190:878-881.
16. Jusko WJ, Pyszczynski NA, Bushway MS, D'Ambrosio R, and Mis SM (1994) Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. J Chromatogr B Biomed Appl 658:47-54.
17. Kabasakalian P, Britt E, and Yudis MD (1966) Solubility of some steroids in water. J Pharm Sci 55:642.
18. Krise JP, Narisawa S, and Stella VJ (1999) A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs. J Pharm Sci 88:922-927.
19. Lai CC, Tsai CH, Tsai FJ, Wu JY, Lin WD, and Lee CC (2002) Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with highperformance liquid chromatography/ electrospray ionization tandem mass spectrometry from dried blood spots. J Clin Lab Anal 16:20-25.
20. Liggins GC and Howie RN (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515-525.
21. Luo Y, Uboh CE, Soma LR, Guan F, Rudy JA, and Tsang DS (2005) Resolution, quantification and confirmation of betamethasone and dexamethasone in equine plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 19:825-832.
22. Mager DE and Jusko WJ (2002) Quantitative structure-pharmacokinetic/ pharmacodynamic relationships of corticosteroids in man. J Pharm Sci 91:2441-2451.
23. Makin HLJ, Honour JW, and Shackleton CHL (1995) General methods of steroid analysis. Part 1. Extraction, purification and measurement of steroids by HPLC, GLC and mass spectrometry, in Steroid Analysis (Makin HLJ, Gower DB, and Kirk BN eds) pp 114-184, Blackie & Son, Ltd., Glasgow.
24. Mollmann H, Balbach S, Hochhaus G, Barth J, and Derendorf H (1995) Pharmacokineticpharmacodynamic correlations of corticosteroids, in Handbook of Pharmacokinetic/Pharmacodynamic Correlation (Derendorf H and Hochhaus G eds) pp 323-361, CRC Press Inc., Boca Raton, FL.
25. Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JR, and Newnham JP (2001) Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol 281:R960-R970.
26. NIH Consensus Panel (1995) NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. J Am Med Assoc 273:413-418.
27. Ogiso T, Ito Y, Iwaki M, Atago H, Tanaka C, Maniwa N, and Ishida S (1987) Percutaneous absorption of dexamethasone acetate and palmitate and the plasma concentration. Chem Pharm Bull (Tokyo) 35:4263-4270.
28. Padbury JF, Ervin MG, and Polk DH (1996) Extrapulmonary effects of antenatally administered steroids. J Pediatr 128:167-172.
29. Petersen MC, Ashley JJ, McBride WG, and Nation RL (1984) Disposition of betamethasone in parturient women after intramuscular administration. Br J Clin Pharmacol 18:383-392.
30. Petersen MC, Collier CB, Ashley JJ, McBride WG, and Nation RL (1983) Disposition of betamethasone in parturient women after intravenous administration. Eur J Clin Pharmacol 25:803-810.
31. Petersen MC, Nation RL, and Ashley JJ (1980) Simultaneous determination of betamethasone, betamethasone acetate and hydrocortisone in biological fluids using high-performance liquid chromatography. J Chromatogr 183:131-139.
32. Rodger MA and King L (2000) Drawing up and administering intramuscular injections: a review of the literature. J Adv Nurs 31:574-582.
33. Rowland M and Tozer TN (1995) Clinical Pharmacokinetics: Concept and Applications. Lippincott Williams & Wilkins, Baltimore.
34. Samtani MN, Schwab M, Nathanielsz PW, and Jusko WJ (2004a) Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats. Pharm Res (NY) 21:2279-2292.
35. Samtani MN, Schwab M, Nathanielsz PW, and Jusko WJ (2004b) Stabilization and HPLC analysis of betamethasone sodium phosphate in plasma. J Pharm Sci 93:726-732.
36. Tamvakopoulos CS, Neugebauer JM, Donnelly M, and Griffin PR (2002) Analysis of betamethasone in rat plasma using automated solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry. Determination of plasma concentrations in rat following oral and intravenous administration. J Chromatogr B Analyt Technol Biomed Life Sci 776:161-168.
37. Taylor RL, Grebe SK, and Singh RJ (2004) Quantitative, highly sensitive liquid chromatographytandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem 50:2345-2352.
38. Tsutsumi H, Nishikawa M, Katagi M, and Tsuchihashi H (2003) Adsorption and stability of suxamethonium and its major hydrolysis product succinylmonocholine using liquid chromatography-electrospray ionization mass spectrometry. J Health Sci 49:285-291.
39. Wald JA, Law RM, Ludwig EA, Sloan RR, Middleton E Jr, and Jusko WJ (1992) Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man. J Pharmacokinet Biopharm 20:567-589.
40. Zuidema J, Kadir F, Titulaer HAC, and Oussoren C (1994) Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II). Int J Pharm 105:189-207.